Structural Biology in Cancer Research

The main part of research is being carried out in the area of cancer. The principal aim is to design and discover innovative and efficient drugs to cure the disease. Structural biology combined with molecular modeling principally aims at drug designing. Ultimately, many researchers in Structural biology carry out cancer research to increase the exploitation of molecular understanding of biomolecules in the advancement of innovative cancer therapies. Cancer immunotherapy is also used which is defined as the response of the immune system to reject cancer. Immunotherapies can be a beneficial way of treating cancer. The malignant tumor cells are attacked by stimulating the immune system as these cells are capable to exploit the fact that cancer cells often have molecules on their surface that can be detected by the tumor-associated antigens (TAAs).

  • Antibody Therapy
  • Cellular Immunotherapy
  • Cytokine Therapy
  • Combinational Immunotherapy

Related Conference of Structural Biology in Cancer Research

May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Structural Biology in Cancer Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in